Small-molecule correctors divert CFTR-F508del from ERAD by stabilizing sequential folding states.

Small-molecule correctors divert CFTR-F508del from ERAD by stabilizing sequential folding states.
复制标题

小分子校正剂通过稳定顺序折叠状态将 CFTR-F508del 从 ERAD 中转移。

DOI:
10.1091/mbc.e23-08-0336
复制
发表时间:
2024
影响因子:
3.3
通讯作者:
Kopito,RonR
Kopito,RonR
中科院分区:
生物学3区
文献类型:
--
作者:
Riepe,Celeste;Wąchalska,Magda;Deol,KirandeepK;Amaya,AnaisK;Porteus,MatthewH;Olzmann,JamesA;Kopito,RonR

文献摘要

相似文献

超过80%的囊性纤维化(CF)患者携带囊性纤维化跨膜传导调节因子(CFTR)的F508del突变,CFTR是上皮细胞顶质膜(PM)上的氯离子通道。F508del损害CFTR折叠,导致其被内质网相关降解(ERAD)破坏。小分子纠正剂作为药物伴侣将CFTR-F508del从ERAD转移,是治疗CF的主要策略,但纠正剂的开发仍在继续,仅对ERAD如何靶向CFTR-F508del有初步的了解。我们进行了全基因组CRISPR/Cas9敲除筛选,以系统地鉴定CFTR-F508del ERAD的分子机制。尽管是er驻留的泛素连接酶,RNF5是E3中最受欢迎的,敲除outnf5只会适度降低CFTR-F508del的降解。在rnf5敲除背景下的亚库筛选发现RNF185是一个冗余连接酶,并证明cfr - f508del ERAD是稳健的。基因-药物相互作用实验表明,校正因子tezacaftor (VX-661)和elexacaftor (VX-445)稳定了序列的、抗rnf5的折叠状态。我们提出,将校正子结合到新生的CFTR-F508del上,通过稳定不是rnf5介导的泛素化底物的折叠状态来改变其折叠景观。
Over 80% of people with cystic fibrosis (CF) carry the F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR), a chloride ion channel at the apical plasma membrane (PM) of epithelial cells. F508del impairs CFTR folding causing it to be destroyed by endoplasmic reticulum associated degradation (ERAD). Small-molecule correctors, which act as pharmacological chaperones to divert CFTR-F508del from ERAD, are the primary strategy for treating CF, yet corrector development continues with only a rudimentary understanding of how ERAD targets CFTR-F508del. We conducted genome-wide CRISPR/Cas9 knockout screens to systematically identify the molecular machinery that underlies CFTR-F508del ERAD. Although the ER-resident ubiquitin ligase, RNF5 was the top E3 hit, knocking outRNF5only modestly reduced CFTR-F508del degradation. Sublibrary screens in anRNF5knockout background identified RNF185 as a redundant ligase and demonstrated that CFTR-F508del ERAD is robust. Gene-drug interaction experiments illustrated that correctors tezacaftor (VX-661) and elexacaftor (VX-445) stabilize sequential, RNF5-resistant folding states. We propose that binding of correctors to nascent CFTR-F508del alters its folding landscape by stabilizing folding states that are not substrates for RNF5-mediated ubiquitylation.